File Download
There are no files associated with this item.
Supplementary
-
Citations:
- Appears in Collections:
Conference Paper: Characteristics and Outcomes of Patients with COVID-19 Admitted to Intensive Care Units – A Report from the Global COVID-19 Critical Care Consortium.
Title | Characteristics and Outcomes of Patients with COVID-19 Admitted to Intensive Care Units – A Report from the Global COVID-19 Critical Care Consortium. |
---|---|
Authors | |
Issue Date | 2021 |
Publisher | Sage Publications Ltd. The Journal's web site is located at http://prf.sagepub.com |
Citation | 9th EuroELSO (European Extracorporeal Life Support Organization) Virtual Congress 2021, 5-7 May 2021. In Perfusion, 2021, v. 36 n. Suppl. 1, p. 39, abstract no. 120 How to Cite? |
Abstract | Objective: SARS-CoV-2 has been reported in almost all countries around the world, and a significant proportion of critically ill patients with COVID-19 require care in the intensive care unit (ICU). There have been few observational cohorts including patients in ICU across different countries. We present summary data from a global critical care consortium.
Methods: The COVID-19 Critical Care Consortium/ ECMOCARD (COVID-19 CCC/ECMOCARD) is an ongoing international multicenter observational study including more than 377 hospitals in 53 countries. Clinical and treatment characteristics are collected for patients with COVID-19 requiring ICU admission.
Results: Data from 2,670 patients with COVID-19 admitted between January 28 and December 19, 2020 were summarized - 182 from Africa, 516 from Asia, 72 from Oceania, 710 from Europe, 343 from Latin America, and 847 from North America. The median (IQR) age was 59 (49 to 68) years, and 909 (34%) were female. 1,283 (49%) patients had hypertension and 830 (32%) had diabetes mellitus. The time from symptom onset to hospital admission was 7 (3 to 10) days, and 1,360 (51%) patients were admitted to ICU on the same day as hospital admission. Upon ICU admission, the heart rate was 95 (80 to 110) beats/min, respiratory rate was 26 (20 to 33) breaths/ min, and oxygen saturation was 93 (89 to 96) %. Details of arterial blood gases and ICU interventions are tabulated. Amongst survivors, ICU length of stay (LOS) was 13 (7 to 25) days, and hospital LOS was 24 (14 to 39) days. As of 31 December 2020, 1,358 (51%) patients were discharged from ICU, and 1,219 (46%) patients survived to hospital discharge. Among 963 (36%) patients who died in hospital, 837 (87%) died within 28 days of ICU admission.
Conclusions: The COVID-19 CCC/ECMO offers a unique global perspective of characteristics and outcomes of patients with COVID-19 requiring admission to the ICU. |
Description | EuroELSO 2021 Poster Abstracts |
Persistent Identifier | http://hdl.handle.net/10722/306554 |
ISSN | 2023 Impact Factor: 1.1 2023 SCImago Journal Rankings: 0.433 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yeung, PNP | - |
dc.contributor.author | Dalton, HJ | - |
dc.contributor.author | White, N | - |
dc.contributor.author | Fraser, JF | - |
dc.date.accessioned | 2021-10-22T07:36:17Z | - |
dc.date.available | 2021-10-22T07:36:17Z | - |
dc.date.issued | 2021 | - |
dc.identifier.citation | 9th EuroELSO (European Extracorporeal Life Support Organization) Virtual Congress 2021, 5-7 May 2021. In Perfusion, 2021, v. 36 n. Suppl. 1, p. 39, abstract no. 120 | - |
dc.identifier.issn | 0267-6591 | - |
dc.identifier.uri | http://hdl.handle.net/10722/306554 | - |
dc.description | EuroELSO 2021 Poster Abstracts | - |
dc.description.abstract | Objective: SARS-CoV-2 has been reported in almost all countries around the world, and a significant proportion of critically ill patients with COVID-19 require care in the intensive care unit (ICU). There have been few observational cohorts including patients in ICU across different countries. We present summary data from a global critical care consortium. Methods: The COVID-19 Critical Care Consortium/ ECMOCARD (COVID-19 CCC/ECMOCARD) is an ongoing international multicenter observational study including more than 377 hospitals in 53 countries. Clinical and treatment characteristics are collected for patients with COVID-19 requiring ICU admission. Results: Data from 2,670 patients with COVID-19 admitted between January 28 and December 19, 2020 were summarized - 182 from Africa, 516 from Asia, 72 from Oceania, 710 from Europe, 343 from Latin America, and 847 from North America. The median (IQR) age was 59 (49 to 68) years, and 909 (34%) were female. 1,283 (49%) patients had hypertension and 830 (32%) had diabetes mellitus. The time from symptom onset to hospital admission was 7 (3 to 10) days, and 1,360 (51%) patients were admitted to ICU on the same day as hospital admission. Upon ICU admission, the heart rate was 95 (80 to 110) beats/min, respiratory rate was 26 (20 to 33) breaths/ min, and oxygen saturation was 93 (89 to 96) %. Details of arterial blood gases and ICU interventions are tabulated. Amongst survivors, ICU length of stay (LOS) was 13 (7 to 25) days, and hospital LOS was 24 (14 to 39) days. As of 31 December 2020, 1,358 (51%) patients were discharged from ICU, and 1,219 (46%) patients survived to hospital discharge. Among 963 (36%) patients who died in hospital, 837 (87%) died within 28 days of ICU admission. Conclusions: The COVID-19 CCC/ECMO offers a unique global perspective of characteristics and outcomes of patients with COVID-19 requiring admission to the ICU. | - |
dc.language | eng | - |
dc.publisher | Sage Publications Ltd. The Journal's web site is located at http://prf.sagepub.com | - |
dc.relation.ispartof | Perfusion | - |
dc.relation.ispartof | 9th EuroELSO Virtual Congress 2021 | - |
dc.title | Characteristics and Outcomes of Patients with COVID-19 Admitted to Intensive Care Units – A Report from the Global COVID-19 Critical Care Consortium. | - |
dc.type | Conference_Paper | - |
dc.identifier.email | Yeung, PNP: pyeungng@hku.hk | - |
dc.identifier.authority | Yeung, PNP=rp02517 | - |
dc.description.nature | abstract | - |
dc.identifier.hkuros | 328587 | - |
dc.identifier.volume | 36 | - |
dc.identifier.issue | Suppl. 1 | - |
dc.identifier.spage | 39, abstract no. 120 | - |
dc.identifier.epage | 39, abstract no. 120 | - |
dc.publisher.place | United Kingdom | - |
dc.identifier.partofdoi | 10.1177/02676591211007763 | - |